Second malignancies complicating Hodgkin's disease: A Southwest Oncology Group 10-year followup

C. A. Coltman, D. O. Dixon

Resultado de la investigación: Articlerevisión exhaustiva

147 Citas (Scopus)

Resumen

Thirty-two second malignancies (21 acute leukemias and 11 solid tumors) were identified among 659 patients with all stages of Hodgkin's disease treated by members of the Southwest Oncology Group. There were no leukemias and one solid tumor among 95 patients treated with radiotherapy alone. The actuarial risk of developing acute leukemia at 7 years was 6.2% for chemotherapy alone, 6.4% for combined modality, and 7.7% for salvage chemotherapy. The incidence of acute leukemia was higher (P = 0.002) among those whose treatment began at ≥ 40 years of age. The actuarial in that group was 20.7% at 7 years. These data are compatible with the hypothesis that chemotherapy alone, combined modality, and salvage chemotherapy have an equivalent oncogenic potential and that patients ≥ 40 years of age have an enhanced susceptibility to these oncogenic stimuli.

Idioma originalEnglish (US)
Páginas (desde-hasta)1023-1033
Número de páginas11
PublicaciónCancer Treatment Reports
Volumen66
N.º4
EstadoPublished - 1982
Publicado de forma externa

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Huella

Profundice en los temas de investigación de 'Second malignancies complicating Hodgkin's disease: A Southwest Oncology Group 10-year followup'. En conjunto forman una huella única.

Citar esto